Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
RO-7568282 in Alzheimer Disease: NCT07781657 Clinical Landscape Report 2026
9 min read
RO-7568282 in Alzheimer Disease: NCT07781657 Clinical Landscape Report 2026
11 September 2026
NCT07781657 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Delpacibart zotadirsen in Infant, Newborn, Diseases: NCT07587242 Clinical Landscape Report 2026
9 min read
Delpacibart zotadirsen in Infant, Newborn, Diseases: NCT07587242 Clinical Landscape Report 2026
11 September 2026
NCT07587242 clinical landscape for Infant, Newborn, Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Trihexyphenidyl Hydrochloride in Tremor: NCT07810296 Clinical Landscape Report 2026
9 min read
Trihexyphenidyl Hydrochloride in Tremor: NCT07810296 Clinical Landscape Report 2026
11 September 2026
NCT07810296 clinical landscape for Tremor: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Decitabine/Cedazuridine in Acute Myeloid Leukemia: NCT07814339 Clinical Landscape Report 2026
9 min read
Decitabine/Cedazuridine in Acute Myeloid Leukemia: NCT07814339 Clinical Landscape Report 2026
11 September 2026
NCT07814339 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Ketamine Hydrochloride in Vaso-occlusive crisis: NCT07682662 Clinical Landscape Report 2026
9 min read
Ketamine Hydrochloride in Vaso-occlusive crisis: NCT07682662 Clinical Landscape Report 2026
11 September 2026
NCT07682662 clinical landscape for Vaso-occlusive crisis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
CRT-402 in Myositis: NCT07778446 Clinical Landscape Report 2026
9 min read
CRT-402 in Myositis: NCT07778446 Clinical Landscape Report 2026
11 September 2026
NCT07778446 clinical landscape for Myositis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Tirzepatide in Endometrioid intraepithelial neoplasia: NCT07812636 Clinical Landscape Report 2026
9 min read
Tirzepatide in Endometrioid intraepithelial neoplasia: NCT07812636 Clinical Landscape Report 2026
11 September 2026
NCT07812636 clinical landscape for Endometrioid intraepithelial neoplasia: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
Read →
Carboplatin in Triple Negative Breast Cancer: NCT07786428 Clinical Landscape Report 2026
9 min read
Carboplatin in Triple Negative Breast Cancer: NCT07786428 Clinical Landscape Report 2026
11 September 2026
NCT07786428 clinical landscape for Triple Negative Breast Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
MRT-6160 in Arthritis, Psoriatic: NCT07801495 Clinical Landscape Report 2026
9 min read
MRT-6160 in Arthritis, Psoriatic: NCT07801495 Clinical Landscape Report 2026
11 September 2026
NCT07801495 clinical landscape for Arthritis, Psoriatic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Casdatifan in Renal Cell Carcinoma: NCT07748988 Clinical Landscape Report 2026
9 min read
Casdatifan in Renal Cell Carcinoma: NCT07748988 Clinical Landscape Report 2026
11 September 2026
NCT07748988 clinical landscape for Renal Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
SOT-106 in Metastatic osteosarcoma: NCT07801222 Clinical Landscape Report 2026
9 min read
SOT-106 in Metastatic osteosarcoma: NCT07801222 Clinical Landscape Report 2026
11 September 2026
NCT07801222 clinical landscape for Metastatic osteosarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Tezepelumab in Severe asthma: NCT07363642 Clinical Landscape Report 2026
9 min read
Tezepelumab in Severe asthma: NCT07363642 Clinical Landscape Report 2026
11 September 2026
NCT07363642 clinical landscape for Severe asthma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →